Best vaginal moisturizer for menopausal dryness

Moisturizer, lubricant, or vaginal estrogen?

A vaginal moisturizer is a water-based gel — often built around hyaluronic acid or a polycarbophil polymer — that clings to the vaginal wall and rehydrates the tissue over days. It is meant to be used on a regular schedule, not only before sex. A personal lubricant, by contrast, reduces friction at the moment of intercourse and washes away afterward; it does nothing for day-to-day dryness. Many people benefit from using both.

Prescription vaginal estrogen (a cream, tablet, or ring) is a different category altogether. Rather than coating the surface, it treats the underlying cause of GSM by restoring estrogen locally to thinning vaginal and vulvar tissue. Because it works on the biology rather than the symptom, guidelines rank it as the most effective option for moderate-to-severe dryness, painful sex, and recurrent urinary symptoms.

What the evidence actually shows

Honest framing matters here. In the MsFLASH randomized trial, published in JAMA Internal Medicine in 2018, postmenopausal women with moderate-to-severe symptoms were assigned to a low-dose vaginal estradiol tablet plus placebo gel, a polycarbophil moisturizer plus placebo tablet, or dual placebo. Over 12 weeks, all three groups improved, and neither the estradiol tablet nor the moisturizer beat placebo gel for the single most bothersome symptom. In other words, regular use of any well-tolerated gel — active or not — helped many participants.

That does not make vaginal estrogen ineffective. A Cochrane systematic review of local estrogen for vaginal atrophy found it consistently improves the tissue and symptoms compared with no treatment, and The Menopause Society 2020 position statement on GSM lists moisturizers and lubricants as first-line for mild symptoms while reserving low-dose vaginal estrogen for moderate-to-severe GSM. The practical takeaway: try a moisturizer first for mild dryness, and escalate to a clinician-prescribed option if it is not enough.

How to choose an over-the-counter moisturizer

Most drugstore products fall into two families: hyaluronic-acid gels and polycarbophil-based gels (the polycarbophil type is the one studied in MsFLASH). Small studies suggest hyaluronic-acid moisturizers can relieve dryness for some women, but the trials are small and short, so treat any single product as worth a fair trial rather than a guaranteed fix.

Practical selection tips: pick a product designed for regular vaginal use rather than a quick-fix lubricant; favor formulas that are pH-appropriate and free of added fragrance, warming agents, and high concentrations of glycerin, which can irritate sensitive menopausal tissue; and use it consistently for at least a few weeks before judging it. If burning, itching, or discharge appears, stop and check with a clinician — that points to irritation or infection, not dryness alone.

When to consider prescription vaginal estrogen

If a moisturizer is not enough — or if you have painful sex, vulvar or vaginal soreness, or recurrent urinary tract infections — it is reasonable to ask a clinician about low-dose vaginal estrogen. It is delivered locally and produces minimal systemic absorption, which is why it is generally considered safe for long-term use in many women who cannot or prefer not to take systemic hormone therapy. ACOG has stated that low-dose vaginal estrogen can even be considered for some women with a history of estrogen-dependent breast cancer after discussion with their oncology team.

Vaginal estrogen is a prescription medicine, and the choice of whether, when, and which form to use rests with a clinician who knows your history. Other prescription options for GSM include vaginal DHEA (prasterone) and the oral medication ospemifene. This page is informational and does not recommend a dose. To see how vaginal estrogen fits alongside patches, gels, and oral therapy, read our visual guide rather than a restatement here.

A note on prescription options

Vaginal estrogen, DHEA (prasterone), and ospemifene are prescription medicines. This page is informational and does not recommend a dose or product. Whether they are appropriate — and which form suits your history — is a decision for a licensed clinician. See how vaginal estrogen compares with patches, gels, and oral therapy in our hormone therapy options visual guide.

Related reading

• Vaginal dryness: treatment options
• Vaginal pH balance in menopause
• Menopause and low libido
• Best menopause telehealth providers

Frequently asked questions

What is the difference between a vaginal moisturizer and a lubricant?

A moisturizer is used on a regular schedule (often every 2 to 3 days) to rehydrate the vaginal tissue over time, while a lubricant is used only at the moment of sex to reduce friction. They address different problems, and many people use both. Neither reverses the underlying tissue changes of menopause.

How often should I use a vaginal moisturizer?

Most vaginal moisturizers are designed for use every 2 to 3 days on a regular schedule, not just before sex. Give any product a fair trial of a few weeks before deciding whether it is working. Follow the specific product instructions and check with a clinician if symptoms persist.

Do vaginal moisturizers work as well as vaginal estrogen?

For mild dryness they can help, and in the 12-week MsFLASH trial an over-the-counter moisturizer performed about the same as a low-dose vaginal estradiol tablet and placebo gel. For moderate-to-severe genitourinary syndrome of menopause, however, professional guidelines rank prescription low-dose vaginal estrogen as the most effective option.

Are hyaluronic acid vaginal moisturizers better?

Some small, short studies suggest hyaluronic-acid moisturizers relieve dryness for certain women, but the evidence is limited and does not clearly show one moisturizer ingredient is superior. Choose a product made for regular vaginal use, avoid irritating additives, and give it a fair trial.

Can I use a vaginal moisturizer if I have had breast cancer?

Non-hormonal vaginal moisturizers and lubricants are generally considered a reasonable first step during and after breast cancer treatment. ACOG has also stated that low-dose vaginal estrogen may be considered for some survivors after discussion with the oncology team. Decisions about any hormonal product should be made with your cancer care clinicians.

Primary medical sources

1. NAMSThe North American Menopause Society. "The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society." Menopause 2020;27(9):976-992.
2. PubMedMitchell CM, et al. "Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial (MsFLASH)." JAMA Intern Med 2018;178(5):681-690.
3. guidelineLethaby A, et al. "Local oestrogen for vaginal atrophy in postmenopausal women." Cochrane Database Syst Rev 2016;8:CD001500.
4. PubMedPortman DJ, Gass ML. "Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy." Menopause 2014;21(10):1063-1068.
5. ACOGACOG Committee Opinion No. 659. "The Use of Vaginal Estrogen in Women With a History of Estrogen-Dependent Breast Cancer." 2016 (reaffirmed).
6. Mayo Clinic. "Vaginal atrophy (genitourinary syndrome of menopause) — Symptoms & causes."